Aesthetic practitioner Dr Souphi Samizadeh has been appointed president of the Royal Society of Medicine’s (RSM) Section of Aesthetic Medicine and Surgery. Following the section’s founding President, Dr Christopher Rowland
Biotechnology company Absci has released positive interim Phase 1 data from its first-in-human trial of investigational anti-prolactin receptor (PRLR) antibody ABS-201. The company details that ABS-201 is an experimental antibody
Title: Research Hot Spots and Trends of Photoelectric Therapy in Facial Rejuvenation: A 20-Year Bibliometric Analysis Based on Web of Science Authors: Lei Guo, et al. Published: Aesthetic Plastic Surgery, December 2025 Keywords: Bibliometric analysis, Facial rejuvenation, Skin resurfacing This …
Title: Non-Surgical Interventions for Reducing Cleft Lip Scars: A Systematic Review and Meta-Analysis Authors: Neda Eslami, et al. Published: The Cleft P Craniofacial Journal, November 2025 Key words: Cleft lip, Laser, Scar This meta-analysis aimed to evaluate the effectiveness of …
Research published in September by the British Association of Aesthetic Plastic Surgeons (BAAPS) highlighted the broader benefits of aesthetic procedures. Published in the Aesthetic Surgery Journal, the research highlighted the health
Aesthetics explores the relationship between botulinum toxin and mental wellbeing A recent retrospective study explored how botulinum toxin type A (BoNT-A) may influence mood by acting on facial muscles and altering neuromuscular feedback mechanisms.1 Published in the Journal of Cosmetic …
New research published in NPJ Women’s Health has found that more than half of women aged 30-35 experience perimenopause symptoms. The self-reported data from 4,432 US women aged 30 and
Pharmaceutical company Galderma has released new research and guidelines on skin care after weight loss medication use. The research reveals loose or sagging skin on the face and neck is
The latest research highlight from Professor Sebastian Cotofana and The Harley Academy Research Group. World-renowned anatomist Professor Sebastian Cotofana shares a key study influencing the world of medical aesthetics. Title: Bridging the Gap Rather Than Filling the Entire Valley – …
Pharmaceutical company Galderma has revealed results from its two phase IIIb trials investigating relabotulinumtoxinA for the treatment of glabellar lines and lateral canthal lines. The first phase IIIb, randomised, double-blind,
